Thrombolysis using recombinant tissue-type plasminogen activator during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest [3]

Resuscitation

Volumn 52, Issue 3, 2002, Pages 308-309

  Böttiger, Bernd W ^a   Padosch, Stephan A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; RECOMBINANT PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CIRCULATION; CONTROLLED STUDY; DRUG CONTRAINDICATION; FIBRINOLYTIC THERAPY; HEART ARREST; HOSPITAL DISCHARGE; HUMAN; LETTER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OUTPATIENT; PRIORITY JOURNAL; RESUSCITATION; TREATMENT OUTCOME;

CARDIOPULMONARY RESUSCITATION; EMERGENCY MEDICAL SERVICES; HEART ARREST; HEMORRHAGE; HUMANS; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0036199597     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(01)00489-0     Document Type: Letter

References (4)

1. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest
2. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial
3. Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation activation after cardiac arrest
4. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation